Market Analysis - Euro Vaccines 2017
Importance and Scope:
Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Euro Vaccines 2017 amasses all the extroverts under one roof of current advances in vaccine research.
Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization.
Why it’s in Paris, France:
Europe is in the top when it comes to vaccines: This area covers two-thirds of industrial research and development activities, 60 percent of the employees and even 90 percent of worldwide production. In Europe a total of 84 percent production is exported, half of it for humanitarian projects in developing countries.
On a global scale, pharmaceutical companies produce about 4.7 billion vaccine portions per year. The production capacities are continuously expanded by the companies: GlaxoSmithKline has doubled its capacity for influenza vaccine production in Dresden for €100 million, while Novartis Behring has completed a € 60 million innovative plant for producing influenza vaccines in Marburg in 2007 and will begin establishing a new EUR 140 million production plant for vaccines against ESME and rabies in 2008.
With new, growth-oriented vaccine manufacturers, France will be able to offer advanced Vaccines in decades to come that are in demand globally and that are highly valued due to their benefits for both industries and Hospitals. As a result, any political commitment in this business area is a good investment.
- Human Vaccines - Infectious & Non Infectious Diseases
- Vaccine Research & Development
- Cancer Vaccines
- HIV Vaccines
- Vaccine Safety & Efficacy
- Vaccination for pregnant women
- Childhood Vaccines
- Vaccine Adjuvants & Delivery Technologies
- Hepatitis Vaccines
- Immunization for Older Adults
- Vaccines against Viral & Bacterial Diseases
- DNA Vaccines
- HPV Vaccines
- Veterinary vaccines
- Tuberculosis Vaccines
- Mucosal Vaccines
- Vaccines against Vector-borne Diseases
- Human Preventive & Therapeutic Vaccines
- Plant-based Vaccines
- Fish Vaccines
- Travel Immunization
Why to attend???
Euro Vaccines 2017 could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in Vaccines and vaccination. Vaccines research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccines research are hallmarks of this conference.
Top 5 global vaccine products based on revenue in 2014 and 2020 (in million U.S. dollars)
Major Vaccines Associations Globally
- European Vaccine Manufacturers
- The European Federation of Pharmaceutical Industries and Associations
- Sclavo Vaccines Association
- The European Malaria Vaccine Development Association
- The International Society for Interferon and Cytokine Research
- The International Union of Immunological Societies
- The Society for Mucosal Immunology
- Federation of Clinical Immunology Societies
- Immune Deficiency Foundation
- Infectious Diseases Society of America
- The Society for Leukocyte Biology
- Transplantation Society
- British Society for Immunology
- The International Society of Neuroimmunology
- European Society of Gene Therapy
- Federation of African Immunological Societies
- Federation of American Societies for Experimental Biology
Top 10 pharmaceutical companies based on global vaccine revenue market share in 2014 and 2020:
This statistic displays the top 10 global pharmaceutical companies based on their vaccine revenue market share worldwide in 2014, and a projection for 2020. Pfizer is expected to account for nearly 21 percent of the global vaccine market share by 2020, largely due to success with its pneumococcal vaccine, Prevnar 13. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Top Global Universities:
- Harvard University
- University of California--San Francisco
- Stanford University
- Yale University
- Johns Hopkins University
- Washington University in St. Louis
- Duke University
- University of Pennsylvania
- Dallas University of California, San Francisco
- Vaccine Research Institute
Companies Associated with Vaccines
- China National Biotec
- Benitec Limited
- Biotron Limited
- Antisense Therapeutics Limited
- GlaxoSmithKline Australia Pty Ltd
- Australian Pharmaceutical Industries (API)
- BioPharmica Limited
Vaccines Market Report:
The global vaccines market is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The major factor driving the growth of this market are high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs.
Key players in the vaccines market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India).
Global vaccine market revenues in 2005, 2009 and 2016 (in billion U.S. dollars)
This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2014, and a projection for 2020. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate 5.8 billion U.S. dollars in revenues by 2020. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Conference Series invites all the participants across the globe to attend “16th Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 19-21, 2017 in Paris, France. The Theme of the conference is "Accelerating Next Generation Vaccines for Global Health" will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.